Axon Enterprise, Inc $AXON Stock Holdings Lessened by Vaughan Nelson Investment Management L.P.

Vaughan Nelson Investment Management L.P. lessened its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 22.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 42,642 shares of the biotechnology company’s stock after selling 12,365 shares during the period. Vaughan Nelson Investment Management L.P. owned 0.05% of Axon Enterprise worth $24,218,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of AXON. Stone House Investment Management LLC bought a new position in Axon Enterprise during the 3rd quarter worth $29,000. New Millennium Group LLC acquired a new position in shares of Axon Enterprise during the third quarter valued at $29,000. Root Financial Partners LLC bought a new position in shares of Axon Enterprise during the third quarter worth about $34,000. Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise in the 2nd quarter worth about $37,000. Finally, Elevation Point Wealth Partners LLC acquired a new stake in shares of Axon Enterprise in the 2nd quarter worth about $56,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity

In other news, Director Jeri Williams sold 157 shares of the stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $490.00, for a total value of $76,930.00. Following the completion of the sale, the director directly owned 1,159 shares of the company’s stock, valued at approximately $567,910. This represents a 11.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Jennifer H. Mak sold 1,500 shares of the business’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $573.45, for a total transaction of $860,175.00. Following the transaction, the chief accounting officer directly owned 12,240 shares in the company, valued at $7,019,028. This trade represents a 10.92% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 23,855 shares of company stock worth $13,299,928 over the last 90 days. Company insiders own 5.70% of the company’s stock.

Analyst Ratings Changes

AXON has been the subject of several recent analyst reports. Northcoast Research upgraded shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 target price for the company in a research report on Tuesday, January 6th. Barclays cut their price target on Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Morgan Stanley lowered their target price on Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a research note on Friday. Sixteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $762.93.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $424.69 on Wednesday. The company’s fifty day moving average is $493.71 and its two-hundred day moving average is $585.07. The company has a market cap of $34.15 billion, a P/E ratio of 279.40, a price-to-earnings-growth ratio of 8.86 and a beta of 1.46. Axon Enterprise, Inc has a 12-month low of $396.41 and a 12-month high of $885.91. The company has a quick ratio of 2.29, a current ratio of 2.53 and a debt-to-equity ratio of 0.53.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.55. The business had revenue of $796.72 million during the quarter, compared to analysts’ expectations of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. Axon Enterprise’s revenue for the quarter was up 38.5% on a year-over-year basis. During the same period in the previous year, the company earned $2.08 earnings per share. Equities analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.